Printer Friendly

THERMOTREX FORMS NEW SUBSIDIARY

 SAN DIEGO, Calif., Feb. 18 /PRNewswire/ -- ThermoTrex Corporation (AMEX: TKN) has formed a new subsidiary, ThermoLase Inc., to develop and eventually commercialize a proprietary new system for providing long-term removal of unwanted hair. The process would use laser technology to remove hair quickly and painlessly. ThermoTrex (TTC) is seeking to fund the development of this technology by selling a minority interest in ThermoLase.
 This new process is subject to approval by the U.S. Food and Drug Adminis-tration. TTC believes it will be faster and also less expensive than electrolysis, the only method now available for the permanent removal of hair. If the technology proves successful, TTC plans to offer this service in a series of clinics located throughout the country.
 ThermoTrex Corporation develops advanced technology in electro-optic and electro-acoustic systems, signal processing, materials technology, lasers, and thermionic and thermoelectric direct-energy conversion. The company also manufactures and markets imaging systems for early detection of breast cancer. In addition, ThermoTrex is developing other commercial products for the medical imaging and avionics industries. ThermoTrex Corporation is a public subsidiary of Thermo Electron Corporation.
 -0- 2/18/93
 /CONTACT: John N. Hatsopoulos of Thermo Electron, 617-622-1111/
 (TMO TKN)


CO: ThermoTrex Corporation ST: Massachusetts IN: SU:

TM -- NE003 -- 7741 02/18/93 09:40 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1993
Words:211
Previous Article:SAY NO TO HIGHER TAXES WITH FIVE MONEY-SAVING TAX TIPS
Next Article:AIR EXPRESS INTERNATIONAL REPORTS FOURTH QUARTER AND YEAR END RESULTS
Topics:


Related Articles
THERMOTREX RECEIVES APPROVAL TO START THERMOLASE CLINICAL TESTING
THERMOTREX CORPORATION ANNOUNCES FIRST QUARTER RESULTS
THERMOLASE RIGHTS OFFERING BEGINS
AMEX LISTS COMMON STOCK OF THERMOLASE CORP.; TENTH THERMO ELECTRON SUBSIDIARY TO JOIN THE AMEX
THERMOLASE COMPLETES TREATMENT PHASE OF CLINICAL TRIALS
THERMOLASE RECEIVES FDA CLEARANCE TO MARKET TECHNOLOGICALLY ADVANCED HAIR-REMOVAL SYSTEM
THERMOTREX SIGNS LETTER OF INTENT TO ACQUIRE BENNETT X-RAY CORPORATION
THERMOLASE CORPORATION ANNOUNCES SECOND QUARTER RESULTS
ThermoLase Corporation Announces Year-End Results
Thermolase to Buy Its Own Securities

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters